Comparison

SARS-CoV-2 Surface GP_2 A2 (HLA-A*02:01) European Partner

Item no. EP14593_1
Manufacturer peptides & elephants
Amount 1 mg
Category
Type Peptides
Applications FC
Specific against SARS-CoV-2
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias VLNDILSRL HLA-A*02:01 Coronavirus(COVID-19) Flow Cytometry
Available
Description
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike or surface glycoprotein (S) and others. The surface glycoprotein is present on the coronavirus envelope and it binds to the ACE2 protein on the host cell surface. SARS-CoV-2 Surface GP_2 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of surface glycoprotein from severe acute respiratory syndrome-related coronavirus.
Keywords
VLNDILSRL HLA-A*02:01 Coronavirus(COVID-19) Flow Cytometry
Sequence
VLNDILSRL
N-Terminus
H
C-Terminus
OH
Purity
0, 95
Counter-Ion
TFA
Allele
HLA-A*02:01
Application
Flow Cytometry
Indication
Coronavirus(COVID-19)
Storage
Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close